Our IonWorks® and PatchXpress® Automated Electrophysiology Systems are used globally to drive drug discovery & development, particularly discovery and screening programs focused on ligand- (including rapidly-desensitising) and voltage-gated ion channels. We launched the first commercially-available automated electrophysiology system – the OpusXpress System – and have continued to deliver unique technologies that enable researchers to leverage the value of direct electrophysiological assays for their discovery research and screening assays.
In addition, ion channel activity can be evaluated to predict potential safety concerns early in the drug discovery process. For example, by using our automated electrophysiology systems, researchers can conduct hERG channel assays to identify potential cardiac safety concerns before expensive toxicology studies are begun.
Visit our main website to learn more.